[11C]flumazenil PET in patients with epilepsy with dual pathology

Epilepsia

Volumn 40, Issue 5, 1999, Pages 566-574

  Juhász, Csaba ^a   Nagy, Ferenc ^a   Muzik, Otto ^a   Watson, Craig ^a   Shah, Jagdish ^a   Chugani, Harry T ^a,b  

^a WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b CHILDREN'S HOSPITAL OF MICHIGAN   (United States)

Author keywords

Dual pathology; Epilepsy; Flumazenil; Hippocampus; Positron emission tomography

Indexed keywords

CARBON 11; FLUMAZENIL; CARBON; DIAGNOSTIC AGENT;

ADOLESCENT; ADULT; ARTICLE; BRAIN ASYMMETRY; BRAIN ATROPHY; CLINICAL ARTICLE; ELECTROENCEPHALOGRAM; EPILEPSY; FEMALE; HIPPOCAMPUS; HUMAN; MALE; NEOCORTEX; NUCLEAR MAGNETIC RESONANCE IMAGING; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; BRAIN CORTEX; COMPARATIVE STUDY; COMPUTER ASSISTED EMISSION TOMOGRAPHY; ELECTROENCEPHALOGRAPHY; METHODOLOGY; MONITORING; PATHOLOGY; SCINTISCANNING; SCLEROSIS;

ADOLESCENT; ADULT; CARBON RADIOISOTOPES; CEREBRAL CORTEX; ELECTROENCEPHALOGRAPHY; EPILEPSY; FEMALE; FLUMAZENIL; HIPPOCAMPUS; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MONITORING, PHYSIOLOGIC; SCLEROSIS; TOMOGRAPHY, EMISSION-COMPUTED;

EID: 0032586971     PISSN: 00139580     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1528-1157.1999.tb05558.x     Document Type: Article

References (52)

1. Babb TL, Brown WJ. Pathological findings in epilepsy. In: Engel J Jr, ed. Surgical treatment of epilepsies. New York: Raven Press, 1987:511-40.
2. Watson C, Cendes F, Fuerst D, et al. Specificity of volumetric magnetic resonance imaging in detecting hippocampal sclerosis. Arch Neurol 1997;54:67-73.
3. Jack CR Jr, Sharbrough FW, Twomey CK, et al. Temporal lobe seizures: lateralization with MR volume measurements of the hippocampal formation. Radiology 1990;175:423-9.
4. Cascino GD, Jack CR Jr, Parisi JE, et al. MRI in the presurgical evaluation of patients with frontal lobe epilepsy and children with temporal lobe epilepsy: pathologic correlation and prognostic importance. Epilepsy Res 1992;11:51-9.
5. Jack CR Jr. MRI-based hippocampal volume measurements in epilepsy. Epilepsia 1994;35(suppl 6):S21-9.
6. Jack CR, Sharbrough FW, Cascino GD, Hirschhorn KA, O'Brien PC, Marsh WR. Magnetic resonance image-based hippocampal volumetry: correlation with outcome after temporal lobectomy. Ann Neurol 1992;31:138-46.
7. Luby M, Spencer DD, Kim JH, de Lanerolle N, McCarthy G. Hippocampal MRI volumetrics and temporal lobe substrates in medial temporal lobe epilepsy. Magn Reson Imaging 1995;13: 1065-71.
8. Nakasato N, Levesque MF, Babb TL. Seizure outcome following standard temporal lobectomy: correlation with hippocampal neuron loss and extrahippocampal pathology. J Neurosurg 1992;77: 194-200.
9. Li LM, Cendes F, Watson C, et al. Surgical treatment of patients with single and dual pathology. Neurology 1997;48:437-44.
10. Sisodiya SM, Moran N, Free SR, et al. Correlation of widespread preoperative magnetic resonance imaging changes with unsuccessful surgery for hippocampal sclerosis. Ann Neurol 1997;41:490-6.
11. Cascino GD, Jack CR Jr, Parisi JI, et al. Operative strategy in patients with MRI-identified dual pathology and temporal lobe epilepsy. Epilepsy Res 1993;14:175-82.
12. Levesque MF, Nakasato N, Vinters HV, Babb TL. Surgical treatment of limbic epilepsy associated with extrahippocampal lesions: the problem of dual pathology. J Neurosurg 1991;75:364-70.
13. Raymond AA, Fish DR, Stevens JM, Cook MJ, Sisodiya SM, Shorvon SD. Association of hippocampal sclerosis with cortical dysgenesis in patients with epilepsy. Neurology 1994;44:1841-5.
14. Cendes F, Cook MJ, Watson C, et al. Frequency and characteristics of dual pathology in patients with lesional epilepsy. Neurology 1995;45:2058-64.
15. Fish DR, Spencer SS. Clinical correlations: MRI and EEG. Magn Reson Imaging 1995;13:1113-7.
16. King D, Spencer SS, McCarthy G, Spencer DD. Surface and depth EEG findings in patients with hippocampal atrophy. Neurology 1997;48:1363-7.
17. Savic I, Roland P, Sedvall G, Persson A, Pauli S, Widen L. In vitro demonstration of reduced benzodiazepine receptor binding in human epileptic foci. Lancet 1988;2:864-6.
18. 11C]Flumazenil positron emission tomography visualizes frontal epileptogenic regions. Epilepsia 1995;36:1225-32.
19. Savic I, Svanborg E, Thorell JO. Cortical benzodiazepine receptor changes are related to frequency of partial seizures: a positron emission tomography study. Epilepsia 1996;37:236-44.
20. Henry TR, Frey KA, Sackellares JC, et al. In vivo cerebral metabolism and central benzodiazepine-receptor binding in temporal lobe epilepsy. Neurology 1993;43:1998-2006.
21. Koepp MJ, Richardson MP, Brooks DJ, et al. Cerebral benzodiazepine receptors in hippocampal sclerosis: an objective in vivo analysis. Brain 1996;119:1677-87.
22. 11C-Flumazenil PET, volumetric MRI and quantitative pathology in mesial temporal lobe epilepsy. Neurology 1997;49:764-73.
23. 18]FDG as PET markers of epileptic foci. J Neurol Neurosurg Psychiatry 1993;56:615-21.
24. Szelies B, Weber-Luxenburger G, Pawlik G, et al. MRI-guided flumazenil- and FDG-PET in temporal lobe epilepsy. Neuroimage 1996;3:109-18.
25. 123I-iomazenil SPECT in presurgical evaluation of temporal lobe epilepsy? J Neurol Neurosurg Psychiatry 1997;62:141-50.
26. Watson C, Andermann F, Gloor P, et al. Anatomic basis of amygdaloid and hippocampal volume measurement by magnetic resonance imaging. Neurology 1992;42:1743-50.
27. Watson C, Jack CR, Cendes F. Volumetric magnetic resonance imaging: clinical applications and contributions to the understanding of temporal lobe epilepsy. Arch Neurol 1997;54:1521-31.
28. Pietrzyk U, Herholz K, Heiss WD. Three-dimensional alignment of functional and morphological tomograms. J Comput Assist Tomogr 1990;14:51-9.
29. Pietrzyk U, Herholz K, Fink G, et al. An interactive technique for three-dimensional image registration: validation for PET, SPECT, MRI and CT brain studies. J Nucl Med 1994;35:2011-8.
30. Müller-Gärtner HW, Links JM, Prince JL, et al. Measurement of radiotracer concentration in brain gray matter using positron emission tomography: MRI-based correction for partial volume effects. J Cereb Blood Flow Metab 1992;12:571-83.
31. Rushing EJ, Barnard JJ, Bigio EH, Eagan KP, White CL. Frequency of unilateral and bilateral mesial temporal sclerosis in primary and secondary epilepsy: a forensic autopsy study. Am J Forensic Med Pathol 1997;18:335-41.
32. Margerison JH, Corsellis JAN. Epilepsy in the temporal lobes. Brain 1966;89:499-530.
33. Mathern GW, Babb TL, Armstrong DL. Hippocampal sclerosis. In: Engel J Jr, Pedley TA, eds. Epilepsy. Philadelphia: Lippincott-Raven, 1998;133-55.
34. Schmid L, Bottlander M, Brouillet E, Fuseau C, Maziere M. Vigabatrin modulates benzodiazepine receptor activity in vivo: a positron emission tomography study in baboon. J Pharmacol Exp Ther 1996;276:977-83.
35. 11C]flumazenil PET in temporal lobe epilepsy with unilateral and bilateral hippocampal sclerosis. Brain 1997;120:1865-76.
36. Cook MJ, Fish DR, Shorvon SD, Straughan K, Stevens JM. Hippocampal volumetric and morphometric studies in frontal and temporal epilepsy. Brain 1992;115:1001-15.
37. Baulac M, Saint-Hilaire JM, Adam C, Martinez M, Fontaine S, Laplane D. Correlations between magnetic resonance imaging-based hippocampal sclerosis and depth electrode investigation in epilepsy of the mesiotemporal lobe. Epilepsia 1994;35:1045-53.
38. Bronen RA, Fulbright RK, Kim JH, Spencer SS, Spencer DD, Al-Rodhan NR. Regional distribution of MR findings in hippocampal sclerosis. Am J Neuroradiol 1995;16:1193-200.
39. Kuzniecky RI, Burgard S, Bilir E, et al. Qualitative MRI segmentation in mesial temporal sclerosis: clinical correlations. Epilepsia 1996;37:433-9.
40. Quigg M, Bertram EH, Jackson T. Longitudinal distribution of hippocampal atrophy in mesial temporal lobe epilepsy. Epilepsy Res 1997;27:101-10.
41. Cendes F, Leproux F, Melanson D, et al. MRI of amygdala and hippocampus in temporal lobe epilepsy. J Comput Assist Tomogr 1993;17:206-10.
42. Reutens DC, Stevens JM, Kingsley D, et al. Reliability of visual inspection for detection of volumetric hippocampal asymmetry. Neuroradiology 1996;38:221-5.
43. Cascino GD, Jack CR Jr, Parisi JE, et al. Magnetic resonance imaging-based volume studies in temporal lobe epilepsy: pathological correlations. Ann Neurol 1991;30:31-6.
44. Lencz T, McCarthy G, Bronen RA, et al. Quantitative magnetic resonance imaging in temporal lobe epilepsy: relationship to neuropathology and neuropsychological function. Ann Neurol 1992; 31:629-37.
45. Watson C, Nielsen SL, Cobb C, Burgerman C, Williamson B. Pathological grading system for hippocampal sclerosis: correlation with magnetic resonance imaging-based volume measurements of the hippocampus. J Epilepsy 1996;9:56-64.
46. Johnson EW, de Lanerolle NC, Kim JH, et al. Central and peripherial benzodiazepine receptors: opposite changes in human epileptogenic tissue. Neurology 1992;42:811-5.
47. Hand KS, Baird VH, Van Paesschen W, et al. Central benzodiazepine receptor autoradiography in hippocampal sclerosis. Br J Pharmacol 1997;122:358-64.
48. Sammaritano M, de Lotbiniere A, Andermann F, Olivier A, Gloor P, Quesney LF. False lateralization by surface EEG of seizure onset in patients with temporal lobe epilepsy and gross focal cerebral lesions. Ann Neurol 1987;21:361-9.
49. 11C]flumazenil binding after epilepsy surgery. Acta Neurol Scand 1998;97:279-86.
50. 11C-flumazenil PET study. Ann Neurol 1996;40:188-98.
51. Rutecki PA, Grossman RG, Armstrong D, Irish-Loewen S. Electrophysiological connections between the hippocampus and entorhinal cortex in patients with complex partial seizures. J Neurosurg 1989;70:667-75.
52. King D, Spencer S. Invasive electroencephalography in mesial temporal lobe epilepsy. J Clin Neurophysiol 1995;12:32-45.